LATEST ALERTS
Description
CBD is considered a medicine of high complexity in Andorra and can only be dispensed in hospital pharmacies. Cannabis is prohibited, though the government commissioned the law firm Roca Junyent for the creation of the draft law on the cultivation of cannabis – the aim of which is to regulate medical cannabis and its cultivation. It is still unclear when the bill will be introduced.
This report provides a summary of the current regulatory framework in place for CBD, hemp and cannabis in Andorra.
Reasons to buy
A CannIntelligence regulatory report will provide you with:
- A clear and detailed understanding of current regulatory requirements affecting this sector in a specific jurisdiction, enabling you to be confident your business and your products are compliant.
- The ability to plan ahead for specific regulatory changes.
- Strategic understanding of the policy climate within the jurisdiction, enabling you to forecast how it might affect business development.
- Sources of further information, for example, links to full texts of legislation and contact details for relevant government offices.
Table of contents
- Executive summary
- Outlook
- Hemp plant
- Extracts
- Finished products containing CBD
- Import and export requirements
- Minor cannabinoids
- Medical cannabis
- Recreational cannabis
- Relevant laws
- Relevant bodies
Methodology
Our research is completely independent and original. It is conducted by CannIntelligence’s multilingual legal analysis team, all specialists in this sector, and goes through a rigorous review and editing process before publication. Research draws on multiple sources, including: online and offline resources and data, specialist legal software, our own extensive databases and report archives, interviews with key stakeholders and government officials, and collaboration with local legal firms and on-the-ground professionals in the jurisdictions covered.
Latest reports
